Neuland Laboratories Limited. — Investor Relations & Filings
Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-29 | English | |
| Copy of Newspaper Publication | 2026-04-21 | English | |
| Copy of Newspaper Publication | 2026-04-14 | English | |
| Updates | 2026-04-09 | English | |
| Disclosure under SEBI Takeover Regulations | 2026-04-07 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-02 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42195178 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-29 | English | ||
| 42189952 | Copy of Newspaper Publication | 2026-04-21 | English | ||
| 42184555 | Copy of Newspaper Publication | 2026-04-14 | English | ||
| 42167031 | Updates | 2026-04-09 | English | ||
| 42199080 | Disclosure under SEBI Takeover Regulations | 2026-04-07 | English | ||
| 42168624 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-02 | English | ||
| 42177861 | Press Release | 2026-04-01 | English | ||
| 42204873 | Trading Window | 2026-03-23 | English | ||
| 42167737 | Loss of Share Certificates | 2026-03-19 | English | ||
| 42165364 | Loss of Share Certificates | 2026-03-12 | English | ||
| 42174823 | Copy of Newspaper Publication | 2026-03-11 | English | ||
| 42176097 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-03-03 | English | ||
| 42178298 | Demise | 2026-03-03 | English | ||
| 42253167 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-02-13 | English | ||
| 42212434 | Updates | 2026-02-11 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Neuland Laboratories Limited. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62255/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62255 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62255 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62255 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62255}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Neuland Laboratories Limited. (id: 62255)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.